OCUP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:51):
Our systems believe the stock currently is undervalued by 0.02% compare to its pairs and should correct upwards.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders...

Stats
Today's Volume	34 939
Average Volume	187 146
Market Cap	40.18M
EPS	$-0.290 ( Q1 \| 2024-03-31 )
Next earnings date	( $-0.290 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.30 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (0.32%)

AADI -2.65%

ABCL 2.57%

ABCM 0.04%

ABEO -2.13%

ABIO -1.69%

ABOS 0.70%

ABSI 2.21%

ABUS -2.30%

ABVX -2.03%

ACAD -0.43%

ACER -17.95%

ACET -5.12%

ACGN 1.29%

ACHL -2.20%

ACHV -0.43%

ACIU -1.25%

ACLX 0.84%

ACRV -4.86%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.12%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT 0.30%

ADTX -3.47%

ADVM -2.68%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.05%

AGEN -2.62%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.52%

AKRO -2.17%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.49%

ALEC -0.46%

ALGS -0.10%

ALKS 0.12%

ALLK -8.86%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 2.09%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.52%

ALVR 2.59%

ALXN 0.00%

ALXO -11.26%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 1.68%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.87%

ANPC -3.15%

APGE -0.83%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 1.11%

APLT -3.49%

APM 4.20%

APOP 0.38%

APRE 0.60%

APTO 6.12%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.40%

ARDS -14.23%

ARDX -0.08%

ARGX -1.03%

ARNA 0.00%

ARPO -0.90%

ARQT -0.99%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.51%

ARWR -1.23%

ASLN -5.07%

ASMB -8.31%

ASND -1.43%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 1.46%

ATRA -4.12%

ATXI 1.93%

ATXS -0.44%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -1.03%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.14%

AVTX -1.25%

AVXL -2.48%

AXLA 0.00%

AXSM -1.33%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.46%

BCAB 4.58%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.89%

BCRX 1.89%

BCTX 8.16%

BCTXW -16.32%

BCYC 0.90%

BDRX -3.85%

BDTX -0.64%

BEAM 1.24%

BFRA -2.91%

BGNE -2.65%

BIOR -5.21%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.48%

BLTE -0.62%

BLU 0.03%

BLUE -0.17%

BMEA -11.04%

BMRN 0.63%

BNOX 4.61%

BNTC -0.42%

BNTX -1.64%

BOLD -8.47%

BOLT 0.72%

BPMC -0.74%

BPTH 1.43%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 30.31%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.31%

CADL -1.23%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.72%

CARM 13.04%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.38%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -9.88%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.41%

CDXS 7.41%

CELC -3.76%

CELU -0.67%

CELUW 11.80%

CERC -1.68%

CERE -1.21%

CERO -3.40%

CEROW -22.75%

CFRX -27.95%

CGEM -2.19%

CGEN -3.31%

CGON -0.98%

CGTX -4.56%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING -0.24%

CINGW 34.95%

CKPT -2.42%

CLBS -16.75%

CLDX -1.99%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.12%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -5.72%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -34.62%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.24%

COYA -1.46%

CPRX -0.92%

CRBP -3.79%

CRBU -4.21%

CRDF -0.89%

CRGX 0.64%

CRIS -1.72%

CRNX -5.75%

CRSP 1.27%

CRTX 2.63%

CRVO -2.50%

CRVS 1.80%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.31%

CTNM -2.33%

CTXR 1.95%

CUE 5.54%

CVAC -2.54%

CVKD -4.57%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.87%

CYTO -2.70%

DARE 5.14%

DAWN 0.67%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.83%

DNLI -0.80%

DNTH -9.24%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.42%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.32%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.26%

ELYM 1.67%

ENGN -5.12%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.12%

ENTO -2.42%

ENTX 1.60%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.38%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.06%

EXAI -0.47%

EXEL -0.22%

EYEG -0.69%

EYEN 1.48%

EYPT 0.97%

FATE -7.53%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.55%

FENC -1.29%

FGEN -4.27%

FHTX 2.67%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.28%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.16%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.57%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.98%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 2.73%

GLTO -0.57%

GLUE -2.51%

GLYC -10.12%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.40%

GNLX 1.11%

GNPX 0.98%

GNTA 3.94%

GOSS -11.86%

GOVX 0.50%

GOVXW -49.04%

GPCR -6.88%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.06%

GRTX 2.57%

GTHX 0.46%

GUTS -4.97%

GXGXW 41.67%

GYRE -5.07%

HALO -1.13%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.70%

HOWL -1.50%

HRMY 0.81%

HRTX 4.27%

HSTO 0.00%

HUMA 0.41%

HUMAW -0.01%

IBRX -3.37%

ICCC 0.22%

ICPT 0.21%

ICU 17.26%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.40%

IFRX -1.80%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 1.74%

IMCR -2.74%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.21%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.66%

INAB -0.01%

INBX 1.13%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.57%

INMB 2.53%

INO -1.69%

INSM -1.14%

INTS -2.75%

INVA 0.50%

INZY 1.14%

IOBT -11.02%

IONS 0.09%

IOVA -2.01%

IPA 0.00%

IPHA 5.58%

IPSC -1.37%

IRON -2.68%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 1.84%

JANX -3.30%

JAZZ -0.62%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.47%

KDNY 0.22%

KMPH -0.34%

KNSA -2.46%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.30%

KRBP -10.00%

KRON 1.05%

KROS -0.94%

KRRO -8.20%

KRTX 0.03%

KRYS -0.98%

KTRA 15.61%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.44%

KYTX -4.25%

KZIA 2.65%

KZR -0.21%

LABP 0.57%

LBPH -2.02%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.18%

LENZ -3.66%

LEXX 0.76%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -9.91%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -2.94%

LPTX -1.10%

LQDA -0.57%

LRMR -2.63%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.47%

LYEL -33.58%

LYRA 0.93%

MACK 0.10%

MBIO -11.56%

MBRX -2.57%

MCRB 1.93%

MDGL -2.75%

MDNA -13.16%

MDWD 0.03%

MDXG -2.36%

MEIP -0.13%

MESO -2.08%

MGNX -3.15%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.98%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.06%

MLYS -6.65%

MNKD -0.76%

MNMD 0.35%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.89%

MREO -2.77%

MRKR 2.57%

MRNA -5.24%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.10%

MRVI -1.60%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -1.23%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.77%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.25%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.73%

NLSP 7.90%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 11.50%

NRIX -0.41%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.17%

NTRBW -31.07%

NUVL -1.14%

NVAX -2.43%

NVCT 4.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -4.67%

OBSV 0.00%

OCEA -0.70%

OCGN 4.66%

OCS -1.00%

OCUL -1.39%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.51%

OMGA 5.86%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.89%

ORGS 0.65%

ORIC -3.12%

ORMP 23.21%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI 2.61%

PASG -1.30%

PBLA -7.50%

PBM -8.21%

PBYI 1.35%

PCSA 0.00%

PCVX 0.26%

PDSB -3.64%

PEPG 2.59%

PGEN -1.80%

PHAR 1.51%

PHAS 0.00%

PHAT -1.16%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 5.78%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -6.84%

PRAX 1.45%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR 0.00%

PRTA -2.11%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.39%

PTCT -0.51%

PTE -0.82%

PTGX -1.14%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.31%

QLGN -2.83%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -2.10%

QURE -0.45%

RAIN -1.63%

RANI 6.42%

RAPT -2.89%

RARE 1.58%

RCKT -7.46%

REGN -0.27%

RENB -3.41%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.41%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.03%

RIGL -3.28%

RLAY -3.41%

RLMD 0.67%

RLYB -0.67%

RNA 0.36%

RNAC -5.94%

RNAZ -0.63%

RNXT 0.01%

ROIV -1.61%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.22%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -0.75%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -2.77%

RYTM -5.13%

RYZB 0.02%

RZLT 1.56%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -2.95%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -5.28%

SEER 0.88%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.90%

SGMT -2.30%

SGTX -2.56%

SIOX 22.63%

SLDB -6.82%

SLGL 2.97%

SLN -4.40%

SLNO -4.00%

SLRX 6.07%

SLS -2.13%

SMMT -2.12%

SNDX 1.48%

SNGX -4.91%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.78%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -3.94%

STRO -2.62%

STSA 0.00%

STTK -0.70%

SURF -0.93%

SVRA -5.13%

SWTX 0.69%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -7.14%

TARS 0.10%

TBPH 0.48%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 1.59%

TCRX 0.57%

TECH -0.11%

TENX 1.91%

TERN -7.86%

TFFP -5.33%

TGTX -2.97%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -4.81%

TNYA -4.38%

TPST 2.91%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -22.36%

TSVT -3.19%

TTNP -7.66%

TVTX 1.13%

TYRA -6.98%

UBX -2.13%

UNCY -3.77%

URGN -1.30%

UTHR -0.28%

VACC 11.36%

VALN -2.89%

VAXX 80.37%

VBIV 0.78%

VBLT -8.77%

VCEL 0.18%

VCNX 10.35%

VCYT -0.70%

VERA -3.35%

VERU -0.34%

VERV -2.58%

VIGL 6.32%

VINC 2.96%

VIR 1.19%

VIRI -1.61%

VIRX 2.40%

VKTX -1.17%

VLON -13.04%

VNDA -2.52%

VOR -2.02%

VRCA 0.14%

VRDN -3.99%

VRNA -1.40%

VRPX 0.38%

VRTX 0.47%

VSTM -0.68%

VTGN -1.05%

VTVT -2.97%

VTYX -1.29%

VXRT -2.93%

VYGR -0.38%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -0.41%

XCUR 3.58%

XENE -2.44%

XERS 2.14%

XFOR 2.52%

XLO 4.43%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.73%

ZNTL -0.36%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-11	Rodgers Richard J	Buy	41 143	Common Stock
2024-06-11	Rodgers Richard J	Buy	35 181	Stock Option (Right to Buy)
2024-06-11	Pepose Jay	Buy	41 143	Common Stock
2024-06-11	Pepose Jay	Buy	35 181	Stock Option (Right to Buy)
2024-06-11	Manuso James S J	Buy	41 143	Common Stock

INSIDER POWER
96.19
Last 94 transactions
Buy: 4 001 388 \| Sell: 115 125

Correlation (AI algo v.1.1b): Undervalued: 0.02% $1.550 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.09 (neutral)

Short: 0.00 (neutral)

Signal:(48.373) Neutral

Ocuphire Pharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ocuphire Pharma, Inc. Correlation - Currency/Commodity

0.39
( neutral )

0.62
( weak )

0.00
( neutral )

0.66
( moderate )

Ocuphire Pharma, Inc. Financials

Annual	2023
Revenue:	$19.05M
Gross Profit:	$19.04M (99.97 %)
EPS:	$-0.460

FY	2023
Revenue:	$19.05M
Gross Profit:	$19.04M (99.97 %)
EPS:	$-0.460

FY	2022
Revenue:	$39.85M
Gross Profit:	$39.85M (99.99 %)
EPS:	$0.900

FY	2021
Revenue:	$589 000
Gross Profit:	$0.00 (0.00 %)
EPS:	$-3.82

Financial Reports:

No articles found.

Ocuphire Pharma, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.